UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1582) 1582
science & technology (1274) 1274
life sciences & biomedicine (1266) 1266
female (911) 911
gabapentin (898) 898
male (895) 895
cyclohexanecarboxylic acids - therapeutic use (788) 788
gamma-aminobutyric acid - therapeutic use (733) 733
amines - therapeutic use (702) 702
middle aged (635) 635
adult (632) 632
cyclohexanecarboxylic acids (532) 532
amines (489) 489
cyclohexanecarboxylic acids - adverse effects (448) 448
gamma-aminobutyric acid (432) 432
neurosciences & neurology (396) 396
aged (390) 390
gamma-aminobutyric acid - adverse effects (386) 386
analgesics - therapeutic use (381) 381
anticonvulsants - therapeutic use (372) 372
amines - adverse effects (365) 365
treatment outcome (363) 363
clinical neurology (355) 355
acetates - therapeutic use (334) 334
anticonvulsants - adverse effects (311) 311
cyclohexanecarboxylic acids - administration & dosage (294) 294
pharmacology & pharmacy (273) 273
gamma-aminobutyric acid - administration & dosage (271) 271
amines - administration & dosage (264) 264
double-blind method (250) 250
acetates - adverse effects (246) 246
abridged index medicus (242) 242
animals (233) 233
dose-response relationship, drug (214) 214
pain (201) 201
analgesics - adverse effects (195) 195
adolescent (194) 194
drug therapy, combination (194) 194
general & internal medicine (190) 190
care and treatment (179) 179
medicine, general & internal (179) 179
pain measurement (176) 176
neurosciences (166) 166
anesthesiology (163) 163
analgesics - administration & dosage (162) 162
drug therapy (158) 158
gamma-aminobutyric acid - analogs & derivatives (154) 154
cyclohexanecarboxylic acids - pharmacology (146) 146
neuralgia - drug therapy (146) 146
epilepsy - drug therapy (143) 143
psychiatry (140) 140
pregabalin (133) 133
randomized controlled trials as topic (131) 131
pain - drug therapy (129) 129
medicine & public health (117) 117
aged, 80 and over (114) 114
child (113) 113
epilepsy (113) 113
fructose - analogs & derivatives (113) 113
anticonvulsants (112) 112
triazines - therapeutic use (112) 112
analysis (111) 111
gamma-aminobutyric acid - pharmacology (111) 111
neuropathic pain (111) 111
anticonvulsants - administration & dosage (110) 110
amines - pharmacology (107) 107
prospective studies (107) 107
time factors (106) 106
analgesics (99) 99
pain, postoperative - drug therapy (98) 98
drug administration schedule (95) 95
acetates - administration & dosage (94) 94
internal medicine (94) 94
neurology (92) 92
surgery (91) 91
clinical trials as topic (89) 89
carbamazepine - therapeutic use (88) 88
research (88) 88
clinical trials (86) 86
retrospective studies (86) 86
rats (84) 84
analgesics, opioid - therapeutic use (83) 83
dosage and administration (81) 81
fructose - therapeutic use (81) 81
young adult (79) 79
administration, oral (78) 78
disease models, animal (78) 78
pain, postoperative - prevention & control (78) 78
drug interactions (77) 77
follow-up studies (75) 75
anticonvulsants - pharmacology (74) 74
pain management (72) 72
epilepsies, partial - drug therapy (71) 71
bipolar disorder - drug therapy (69) 69
quality of life (69) 69
mice (68) 68
triazines - adverse effects (67) 67
cyclohexanecarboxylic acids - pharmacokinetics (65) 65
lamotrigine (65) 65
gamma-aminobutyric acid - pharmacokinetics (62) 62
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1657) 1657
German (30) 30
Spanish (24) 24
French (22) 22
Japanese (15) 15
Italian (8) 8
Chinese (4) 4
Portuguese (4) 4
Hungarian (3) 3
Norwegian (3) 3
Russian (3) 3
Swedish (3) 3
Danish (2) 2
Finnish (2) 2
Polish (2) 2
Dutch (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane library, ISSN 1465-1858, 06/2017, Volume 2020, Issue 2, pp. CD007938 - CD007938
.... Objectives To assess the analgesic efficacy and adverse effects of gabapentin in chronic neuropathic pain in adults... 
Amines | Soft tissue disorders | Gabapentin | Fibromyalgia | 2019 3. Chronic pain | Peripheral neuropathy | Analgesics | Painful neuropathy (Shared area of common interest with Pain, Palliative and Supportive Care (PaPaS) Group) | Fibromylagia | Neuralgia, Postherpetic | Pharmacological therapies | Chronic Pain | gamma‐Aminobutyric Acid | Anti‐epileptic drug treatment (Please refer to the PaPaS Group) | Rheumatology | [R] PaPaS Group ‐ Gabapentin for acute and chronic pain | Painful neuropathy | Management | Pain & anaesthesia | Diabetic Neuropathies | Randomized Controlled Trials as Topic | Neurology | Chronic non‐cancer pain | Numbers Needed To Treat | 2019 3.1 Neuropathic pain | Cyclohexanecarboxylic Acids | Neuralgia | Medicine General & Introductory Medical Sciences | Chronic Disease | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Chronic Pain - drug therapy | Humans | Cyclohexanecarboxylic Acids - adverse effects | Analgesics - administration & dosage | Cyclohexanecarboxylic Acids - administration & dosage | gamma-Aminobutyric Acid - administration & dosage | Diabetic Neuropathies - drug therapy | Neuralgia, Postherpetic - drug therapy | Neuralgia - drug therapy | Fibromyalgia - drug therapy | Amines - administration & dosage | Adult | Amines - adverse effects | Analgesics - adverse effects | gamma-Aminobutyric Acid - adverse effects | Index Medicus
Journal Article
Journal of neurology, ISSN 0340-5354, 3/2010, Volume 257, Issue 3, pp. 322 - 327
A prospective examiner-blind, cross-over study was conducted to compare the efficacy of memantine (40 or 60 mg/day) and gabapentin (1,200 mg/day) as therapy... 
Neurology | Neurosciences | Multiple sclerosis | Memantine | Medicine & Public Health | Gabapentin | Acquired nystagmus | Drug therapy | Neuroradiology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Single-Blind Method | Neural Pathways - drug effects | Prospective Studies | Humans | Middle Aged | Clinical Protocols | Male | gamma-Aminobutyric Acid - administration & dosage | Eye Movements - drug effects | Brain Stem - drug effects | Dose-Response Relationship, Drug | Young Adult | Amines - administration & dosage | Adult | Female | Amines - adverse effects | Nystagmus, Pathologic - etiology | Neural Pathways - physiopathology | Excitatory Amino Acid Antagonists - adverse effects | Memantine - administration & dosage | Nystagmus, Pathologic - drug therapy | gamma-Aminobutyric Acid - adverse effects | Eye Movements - physiology | Cyclohexanecarboxylic Acids - adverse effects | Cyclohexanecarboxylic Acids - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Treatment Outcome | Nystagmus, Pathologic - physiopathology | Cross-Over Studies | Multiple Sclerosis - complications | Brain Stem - physiopathology | Memantine - adverse effects | Complications and side effects | Nystagmus | Causes of | Dosage and administration | Index Medicus
Journal Article
Drug safety, ISSN 0114-5916, 2/2018, Volume 41, Issue 2, pp. 213 - 228
Journal Article